NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

市场调查报告书

巨细胞病毒(CMV)检验(体外诊断)-全球市场分析及预测模式(COVID-19对市场造成的影响)

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact)

出版商 GlobalData 商品编码 979515
出版日期 内容资讯 英文
订单完成后即时交付
价格
巨细胞病毒(CMV)检验(体外诊断)-全球市场分析及预测模式(COVID-19对市场造成的影响) Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact)
出版日期: 2021年06月30日内容资讯: 英文
简介

本报告详细探讨2020年后COVID-19对全球巨细胞病毒测试市场的影响。巨细胞病毒(CMV)是引起全球范围内先天性感染的广泛分布的病原体。CMV高危人群包括免疫力低下的患者(艾滋病患者或器官移植受者),早产儿和新生儿。

CMV是发达国家中最常见的先天性病毒感染,可引起儿童神经系统疾病以及感音神经性耳聋。先天性巨细胞病毒感染发生在原发性和继发性巨细胞病毒感染的妇女所生的孩子中,这意味著受孕前的免疫力无法抵抗病毒的传播。

尽管传播的风险较低,但研究表明,即使在工业化国家中,大多数先天性巨细胞病毒感染也归因于继发性(或非原发性)母体感染,这很可能是因为血清反应阳性的妇女发生了更多的妊娠。本报告涵盖孕妇和免疫受损患者的CMV测试。

本报告提供巨细胞病毒(CMV)检验市场相关调查,提供市场概要,以及2015~2030年的市场预测,各市场区隔,各国的趋势等资讯。

  • 主要的产业趋势洞察
  • 2015年~2030年各分类市场预测
  • 手术数量,台数,平均销售价格,各分类市场价值相关详细资料

全球地区,各国趋势

  • 各国分析
  • SWOT分析
  • 竞争趋势

健康护理系统概要

  • 医疗保健制度的各国概要
  • 各国给付方针
  • 国家固有的医疗技术相关法规趋势

网罗的企业:DiaSorin Spa,F. Hoffman-LaRoche Ltd,Qiagen NV,Quidel Corp,bioMerieux SA,Bio-Rad Labs Inc.,其他

觀察对象国家:美国,英国,德国,法国,义大利,西班牙,巴西,中国,印度,俄罗斯,日本,澳洲,加拿大,墨西哥,韩国,丹麦,爱尔兰,荷兰,纽西兰,南非,瑞典,瑞士,奥地利,比利时,芬兰,以色列,挪威,波兰葡萄牙,台灣,捷克,希腊,匈牙利,土耳其,埃及,沙乌地阿拉伯,阿拉伯联合大公国,阿根廷,智利

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDME625MM

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Cytomegalovirus(CMV) tests market for the year 2020 and beyond. Cytomegalovirus(CMV) tests are performed for detection of Cytomegalovirus. The CMV infections are mostly prevalent in pregnant women, immunocompromised patients and infants. The tests carried out in laboratories are considered.

The CMV tests include Enzyme Immuno Assay (EIA) Tests, Nucleic Acid Amplification Tests (NAATs) and other CMV test kits.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Cytomegalovirus(CMV) tests and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Cytomegalovirus(CMV) tests market revenue by segment and market outlooks from 2015-2030.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Cytomegalovirus market.
  • Competitive dynamics insights and trends provided for Cytomegalovirus market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Abbott Laboratories, Danaher Corp, bioMerieux SA, MBL International Corporation, Bio-Rad Laboratories, Inc, DiaSorin SpA, Luminex Corp, Qiagen NV, Quidel Corp, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

Who should buy this report?

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Cytomegalovirus (CMV) tests market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Cytomegalovirus(CMV) tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Cytomegalovirus(CMV) tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Cytomegalovirus(CMV) tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Cytomegalovirus(CMV) tests market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.